February is American Heart Month, an annual campaign that aims to raise awareness about heart health and cardiovascular ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

A growing body of research suggests that mindfulness-based interventions may reduce stress, in turn helping to reduce ...

February is American Heart Month, an annual campaign that aims to raise awareness about heart health and cardiovascular diseases.

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Microplastics pose a threat to heart health, causing harmful changes in vascular cells and increasing the risk of ...

Heart transplant is a scary and serious surgery with a high cost, but for patients with heart failure it can be the only ...